Blog Archives
icon_analytics

Population Health Management in Real-Time

Real-time population health usecases are everywhere in healthcare. Imagine a patient recently diagnosed with congestive heart failure (CHF). As soon as his physician saves the new diagnosis within the EHR, the patient is automatically enrolled in a program and sent

Share
icon_analytics

Point Solutions vs. Data Hoarders: K.O. Match

As I wrap up my research into clinical analytics/population health for this year’s Market Trends report, I have been enjoying long and entertaining calls with the vendor community. Without fail, vendors enjoy lobbing insults at their competition (though I might

Share
icon_analytics

Financial Analytics Bleeding into Population Health Management

It appears that “population health management” (PHM) just has a better ring to it than “accountable care” or “HMO 2.0”. Increasingly, PHM is becoming an umbrella term for all of the operational and analytical HIT tools needed for the transition

Share
icon_analytics

Analytics, Pop Health & Painful Feet at HIMSS14

HIMSS14….  brought me to the highest of highs and the lowest of lows. As in HIMSS past, I found myself surrounded by people genuinely committed to fixing our defunct healthcare system — and the population health management group-chant was louder

Share

Barefoot at HIMSS? Just Trying to Follow Dr. Google’s Orders

If you see me in flip flop sandals, Vibram Five Fingers (VFF), or a barefoot-style shoe at HIMSS14 — please withhold fashion judgment. Since Jan 1, 2014, I have been performing a little “care management” on myself — as ordered

Share
icon_patient_engagement

Payers Refocus Efforts on ROI for Member Engagement

What a difference a year has made to the payer market. In late 2012 Chilmark Research published the first version of our Payer Benchmark report — detailing how leading payers were beginning to adopt emerging consumer technologies. We found a market

Share
icon_phm

The Two Faces of Population Health Management

As we head into the New Year, we at Chilmark Research have been thinking a lot about how we will approach Population Health Management (PHM) in 2014, and beyond. PHM is actually a pretty unfortunate term for the data-driven business

Share

Crashes, Bugs, and Major Usability Issues at Covered California

I have spent the past few days struggling to apply for insurance on California’s HIX, CoveredCA. Early on in the application process I tried to withhold judgment, but have since learned that coveredca.com has a price tag of $360M, awarded

Share

Data-Driven Patient Outreach: Financially Efficient or Morally Compromised?

I recently spoke with a clinical analytics vendor about one of their provider customer’s bizarre decisions – to no longer encourage a subset of their diabetic population to take the HbA1C test. The reason? These diabetics were covered under a

Share

Haunted by the Past: The Legacy of Claims Data Continues

Assume for the moment that we are indeed looking towards a future of widespread value-based reimbursement and provider-led population health management (PHM). Claims data should come to be seen as increasingly irrelevant, right? This is what I initially assumed before

Share

Clinical Data Has Arrived. Now What?

Last year it became clear that the term ACO-enablement was going out of fad, and a new buzzword — population health management (PHM) — was surfacing. After interviews with several industry stakeholders, it soon became clear to us at Chilmark

Share

At the Intersection of Obesity and HIT

We Americans are on a very terrifying path, health-wise, based on the latest obesity projections from RWJF. Medical “innovations” around the obesity epidemic are unsettling, to say the least. Most recently, Dean Kamen (of Segway fame) filed a patent for

Share

300 Million Asthmatics and the Future of Respiratory Monitoring

A few years ago my daughter began developing asthma-like symptoms brought on by reactions to pollen, cat dander, and other triggers.  I can still remember the panic I felt in my chest the first time she ran to me wheezing

Share

HIMSS11 Shrinking the World Down One Size

  Like Dilbert, I left HIMSS11 with a sense of scale that was somewhat skewed. The first time I crossed the pedestrian bridge overlooking the vendor showroom, I was immediately struck by the vastness of it all.  The showroom itself

Share

A Tale of Two Medical Records

This is a tale of my nearly year-long attempt to integrate my family’s medical records from a small outpatient provider (MIT Medical) into my Kaiser Permanente HealthConnect EMR. From 2008-2010 my family was living Boston where I was getting my

Share

What Do Future MU Requirements Mean for mHealth, If Anything?

What are some of my favorite things?  “Raindrops on roses” and “whiskers on kittens” definitely make the list.   How about the task of combing over a large chunk of new Meaningful Use (MU) proposed requirements? … Not so much… though

Share

NaviNet Acquires Prematics: a Testament to the Ubiquity of Smartphones in the Exam Room

Last week, NaviNet announced its acquisition of Prematics, a company founded a few short years ago targeting the market for mHealth provider solutions. While there are significant synergies and overlap between the two companies’ product offerings, NaviNet’s main driver with

Share

Don’t Rule-out the Mobile Browser

I recently had the opportunity to speak with Henry J. Feldman, M.D., instructor of medicine at Harvard Medical School at the Beth Israel Deaconess Medical Center (BIDMC).  Dr. Feldman also serves as Chief Information Architect in addition to practicing as

Share

Business Drivers for Mobility in the Enterprise

John mentioned in an earlier post, “Is the mHealth hype justified?” how the word ‘mHealth’ has acquired a broad, unwieldy set of definitions.  The mHealth term is now practically useless (except as a buzzword).  In my research to date, I

Share

Who We Are

Chilmark Research is the only industry analyst firm focusing solely on health IT. We combine proven research methodologies with intelligence and insight to provide cogent analyses of the emerging technologies that have the greatest potential to improve healthcare. We do not shy away from making tough calls, and are respected in the industry for our direct and thoughtful commentary.